Comparison of multiple oncotype DX from the same patient.

For women with breast cancer in whom multiple Oncotype DX Recurrence Scores (RS) are obtained, RS concordance utilizing current NCCN recommendations has not been evaluated. Patients with two or more RS were identified. RS were stratified by NCCN guidelines and compared for concordance.